Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Department of Evolutionary Ecology and Genetics, Zoological Institute, Kiel University, Kiel, Germany.
mBio. 2024 Feb 14;15(2):e0315523. doi: 10.1128/mbio.03155-23. Epub 2024 Jan 12.
Ionophores are antibacterial compounds that affect bacterial growth by changing intracellular concentrations of the essential cations, sodium and potassium. They are extensively used in animal husbandry to increase productivity and reduce infectious diseases, but our understanding of the potential for and effects of resistance development to ionophores is poorly known. Thus, given their widespread global usage, it is important to determine the potential negative consequences of ionophore use on human and animal health. In this study, we demonstrate that exposure to the ionophore monensin can select for resistant mutants in the human and animal pathogen , with a majority of the resistant mutants showing increased growth rates and/or in mice. Whole-genome sequencing and proteomic analysis of the resistant mutants show that the resistance phenotype is associated with de-repression of purine synthesis, which could be achieved through mutations in different transcriptional regulators including mutations in the gene , the repressor of the purine synthesis pathway. This study shows that mutants with reduced susceptibility to the ionophore monensin can be readily selected and highlights an unexplored link between ionophore resistance, purine metabolism, and fitness in pathogenic bacteria.IMPORTANCEThis study demonstrates a novel link between ionophore resistance, purine metabolism, and virulence/fitness in the key human and animal pathogen . The results show that mutants with reduced susceptibility to the commonly used ionophore monensin can be readily selected and that the reduced susceptibility observed is associated with an increased expression of the purine synthesis pathway. This study increases our understanding of the impact of the use of animal feed additives on both human and veterinary medicine.
离子载体是一类通过改变细胞内必需阳离子(钠和钾)的浓度来影响细菌生长的抗菌化合物。它们在畜牧业中被广泛应用,以提高生产力和减少传染病,但我们对离子载体产生抗性的潜力和影响的了解还很有限。因此,鉴于它们在全球范围内的广泛使用,确定离子载体使用对人类和动物健康的潜在负面影响非常重要。在这项研究中,我们证明了暴露于离子载体莫能菌素可以选择人类和动物病原体中的耐药突变体,其中大多数耐药突变体表现出生长速度增加和/或在小鼠中增加。耐药突变体的全基因组测序和蛋白质组学分析表明,耐药表型与嘌呤合成的去阻遏有关,这可以通过不同转录调节剂(包括嘌呤合成途径的抑制剂基因的突变)中的突变来实现。这项研究表明,对离子载体莫能菌素敏感性降低的突变体可以很容易地被选择出来,并强调了离子载体抗性、嘌呤代谢和致病性细菌适应性之间未被探索的联系。
这项研究在关键的人类和动物病原体中证明了离子载体抗性、嘌呤代谢和毒力/适应性之间的一种新联系。结果表明,对常用离子载体莫能菌素敏感性降低的突变体可以很容易地被选择出来,并且观察到的敏感性降低与嘌呤合成途径的表达增加有关。这项研究增加了我们对动物饲料添加剂使用对人类和兽医医学的影响的理解。